Summary
Overview
Work History
Education
Skills
Certification
Additional Information
Software
Timeline

Khodr ISSA

Research And Development Scientist
Villeneuve D'ascq

Summary

Hardworking Researcher Scientist bringing 9 years of expertise in molecular biology, immunotherapy of cancer and cardiovascular disease. Skilled multitasker with excellent communication and problem-solving skills. Proven history of maintaining equipment and lab areas in alignment with regulatory guidelines.



Overview

14
14
years of professional experience
9
9
years of post-secondary education
4
4
Certifications
3
3
Languages

Work History

Research Scientist

Proteomics, Inflammatory Response Mass Spectrometry (PRISM) Laboratory, Inserm U1192
Villeneuve d'Ascq
10.2021 - 05.2023
  • Understanding the mechanisms that regulate the heterogeneity and pro-tumoral activity of tumor-associated macrophages
  • Development of an immunotherapy strategy CAR-Macrophages (CAR-MACs) via the expression of a synthetic biomarker in the context of Glioblastoma
  • Development a novel assay of imagery based on an aptamer probe coupled to mass spectrometry (MS) detection
  • Evaluate and deliver novel therapeutic concepts into clinical development

Head of Molecular Diagnostics Department

Doctors' Center Laboratory
Beirut
07.2019 - 09.2021
  • Provided scientific and technical expertise in special tests, flow cytometry, NGS, HLA typing, Sequencing and molecular biology tests for oncological, viral infections as well as cardiovascular and hereditary diseases.
  • Mentored and co-mentored several technicians from different background and ethnicities to fully achieve Lab goals. Successfully organized seminars, meetings, team-building activities, and collaborations with different hospitals and clinicians
  • Gained extensive knowledge in data entry, analysis and reporting.
  • Identified issues, analyzed information and provided solutions to problems.


Research Project Manager

American University of Beirut Medical Center (AUBMC)
Beirut
03.2016 - 03.2021
  • Developed and initiated different projects, managed costs, and monitored performance.
  • Achieved project deadlines by coordinating with contractors to manage performance.
  • Identified plans and resources required to meet project goals and objectives.
  • Planned, designed, and scheduled phases for large projects.

Postdoctoral Research Fellow

Marie Skłodowska-Curie fellowship « Nanoresistance »
Manchester & Nicosia
09.2013 - 08.2015
  • Management of resistance to Tyrosine Kinase Inhibitors with advanced Nanosystems.
  • In vivo validation of efficacy of Nanoparticles in Orthotopic model of colorectal cancer, and Glioblastoma Cancer Model.
  • Biodistribution, Pharmacokinetics and Pharmacodynamics studies.
  • Nanofiber membranes for sustained TKI-delivery in solid tumors in situ.
  • Interaction of the nanometric delivery platforms with living systems including transportation kinetics across barriers.
  • Collaborated with 4 multidisciplinary team members to accomplish our research goals.

Doctoral Researcher

Laboratoire de Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), INSERM (UMR_1116)
Nancy
09.2009 - 06.2013

Protector effect of hydrogen sulfide (H2S), Activated protein C (APC) and dexamethasone (Dexa) in hemodynamic and inflammatory modulation of Ischemia-Reperfusion.

  • Collaborated with leadership team to identify relevant questions and determine best methods of collection.
  • Wrote research papers, reports, reviews, and summaries regarding cardiovascular disease
  • Gathered and organized information for research purposes.
  • Performed research into study topics to increase knowledge and to provide valuable contributions.
  • Identified sources of funding to prepare research proposals and submit funding applications

Internship Trainer

Laboratoire de Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), INSERM (UMR_1116)
Nancy
01.2009 - 07.2009

Effect of hydrogen sulfide (H2S) in an experimental model of hemorrhagic shock.

  • Partnered with department managers to help intern gain competencies and confidence.
  • Reinforced employability skills and helped intern understand and interpret work culture.
  • Attended job orientation with intern and reiterated policies and practices to facilitate successful work experience.


Education

Ph.D. - Life Sciences And Health (Molecular Biology & Pharmacology)

Faculty of Medicine, Lorraine University, Nancy, France
09.2009 - 06.2013

Master of Science - Bioengineering And Pharmacology

Faculty of Pharmacy, Henri Poincare University, Nancy, France
09.2008 - 07.2009

Master of Science - Molecular Biology And Biochemistry

Faculty of Sciences, Henri Poincare University, Nancy, France
09.2007 - 07.2008

Bachelor of Science - Biochemistry

Faculty of Sciences, Lebanese University, Beirut, Lebanon
10.2002 - 06.2006

Skills

    Laboratory experiments

undefined

Certification

Certified [Clinical Research Coordinator (CRC) Advanced], [CITI]

Additional Information

Books:

Issa K. « Hydrogen sulfide, activated Protein C and dexamethasone in Ischemia- Reperfusion / Sulfure d'hydrogène, Protéine C activée et Déxamethasone dans l'Ischémie-Reperfusion”. Presses Acad é miques Francophones 2013 .


Peer-Reviewed Publications:

1. Issa K , Kimmoun A, Collin S, Ganster F, Fremont-Orlowski S, Asfar P, Mertes PM, Levy B. Compared effects of inhibition and exogenous administration of Hydrogen Sulfide in Ischaemia-Reperfusion injury. Critical Care. 2013 Jul 10;17(4): R129

2. Kimmoun A, Ducrocq N, Sennoune N, Issa K , Montemont N, Gibot S, Levy B. Efficient extra and intracellular alkalinization improves cardiovascular functions in severe lactic acidosis induced by hemorrhagic shock. Anesthesiology. 2014 Apr;120(4):926-34

3. Issa K , Kettany N, Perrin J, Montemont C, Levy B. Effects of Activated protein C and Dexamethasone in intestinal Ischemia/Reperfusion. In Preparation

4. Kimmon A, Delemazure J, Dessales N, Djillali A, Fremont S, Ducrocq N, Issa K , Levy B. Beta-1-adrenergic inhibition improves cardiac and vascular functions in experimental septic shock. Critical Care Med. 2015 Sep; 43(9): e332-40.

5. Fardoun M, Nassif J, Issa K , Baydoun E, Eid H.A. Raynaud's phenomenon: a Brief Review of the Underlying Mechanisms. Front Pharmacol. 2016 Nov 16;7:438

6. Fardoun M, Al-Shehabi T, El-Yazbi A, Issa K , Zouein F, Maaliki D, Iratni R, Eid H.A. Ziziphus nummularia inhibits inflammation-induced atherogenic phenotype of human aortic smooth muscle cells. Oxid Med Cell Longev. 2017 ;2017:4134093

7. Maaliki D, Issa K , Al Shehabi T, Elyazbi A, Eid H.A. « The Role of α2-Adrenergic receptors in Hypertensive Pre-eclampsia: A Hypothesis ». Microcirculation. 2019 Jan;26 (1): e12511

8. Dehaini H, Awada H, El-Yazbi A, Zouein F, Issa K , Eid H.A, Ibrahim M, Badran A, Baydoun E, Pintus G, Eid A. « MicroRNAs as Potential Pharmaco-Targets in Ischemia-Reperfusion Injury Compounded by Diabetes MicroRNAs as Potential Pharmaco-Targets in Ischemia-Reperfusion Injury Compounded by Diabetes ». Cells. 2019 Feb;8 (2), 152

9. Naji S, Issa K , Eid A, Iratni R, Eid H.A. « Cadmium Induces Migration of Colon Cancer Cells: Roles of Reactive Oxygen Species, p38 and Cyclooxygenase-2 ». Cell Physiol and Biochem. 2019 May;52(6):1517-1534

10. Badran A, Baydoun E, Samaha A, Anwar M, Iratni R, Eid H.A and Issa K « Marjoram relaxes rat Thoracic Aorta via a PI3-K/Akt/eNOS/cGMP Pathway ». Biomolecules. 2019 Jun; 9(6): 227.

11. El-Khatib M, Mroueh A, Rafeh R, Sleiman F, Fouad H, Saad E, Fouda M, Elgaddar O, Issa K , Eid H.A, Abd-Elrahman K, El-Yazbi A. « Amelioration of perivascular adipose inflammation reverses vascular dysfunction in a model of non-obese prediabetic metabolic challenge: Potential role of anti-diabetic drugs ». Translational Research . 2019 Dec ; 214:121-143.

12. Fardoun M, Issa K , Maaliki D, A Nasser S, Baydoun E, Eid H.A. « Estrogen Increases Expression of Vascular Alpha 2C Adrenoceptor Through the cAMP/Epac/JNK/AP-1 Pathway and Potentiates Cold-Induced Vasoconstriction ». Vascular Pharmacol . 2020 May; 11;106690

13. Jaber H, Issa K , Eid H.A, Saleh F. « The therapeutic effects of adipose-derived mesenchymal stem cells on obesity and its associated diseases in diet-induced obese mice ». Scientific Reports-Nature research. 2021 March; 11: 6291.

14. Issa K , Fardoun M, Eid H.A. « Cortisol-induced hypertension: a novel role for Rap1, Rho kinase and vascular alpha 2C adrenoceptor». In Preparation *

15. Hamadeh L, Issa K , Eid H.A. « High Glucose Modulates Phenotype of Human Arteriolar Smooth Muscle Cells ». In Preparation *

16. Issa K , Fardoun M, Eid H.A. « Development of a novel protocol for isolation of Human Vascular Smooth Musclar Cells ». In Preparation *

In Preparation *: Final confidential copy available upon request


Abstracts:

1. Khodr Issa , Ali Eid. Cooling evokes spatial and functional rescue of vascular alpha 2C-Adrenoceptors: Role of ROS, Rho and filamin. British Society of Cell Biology-British Society of Developmental Biology Joint Meeting , University of Warrick, UK; April 2019

2. Manal Fardoun, Khodr Issa , Ali Eid and Elias Baydoun. Estrogen increases expression of human vascular alpha 2C adrenoceptor via the Epac-JNK pathway. British Pharmacological Society ; December 2018; London, UK.

3. Lina Hamadeh, Khodr Issa , Ali Eid . High glucose modulates phenotype of human arteriolar smooth muscle cells. British Society of Developmental Biology , University of Warrick, UK; 2018 .

4. Rachel Njeim, Khodr Issa and Ali Eid. Alpha-2c Adrenergic Receptor Promotes the Malignant Phenotype of Colon Cancer Cells. ASPET 2018 at the Experimental Biology Meeting.


Poster Presentation:

1. Issa K , Fardoun M, SalehA, Samaha A, IratniR, BaydounE, EidA. « The Vasorelaxant Effect of Marjoram in Rat Thoracic Aorta is mediated Via a PI3-K/Akt/eNOS/cGMP Pathway».Kamal A. Shair Central Research Science Laboratory 5 th Research Conference, AUB, Beirut, Lebanon. April 2016

2. Pitris C, Issa K , Stylianou P, Odysseos A. «Quantification of spatiotemporal distribution of the nanoparticles from fluorescence microscopy images of tissue sections». ICoN, Limassol, Cyprus. October 2015

3. Nikos M, Issa K , Odysseos A. «Breaking through the brain tumor barrier». ICoN, Limassol, Cyprus. October 2015

4. Issa K , Christou Y, NarayanA, Stylianou P, Pitris C, Galli R, Odysseos A. «γ-Tocotrienol modulate self-renewal potential in tumors with differential expression of the epidermal growth factor receptor». COST meeting, Athens, Greece. March 2015.

5. Odysseos A, Strongilos A, Davila- Ibanez AB, Stylianou P, Angelou E, Issa K , Iliopoulou S, Maranti A, Othonos KM, Pitris C, Siaugue JM. «Theranostic Silica Core-Shell Nanoparticles Decipher Drug Resistance at the ERB-axis with Nuclear Delivery of Targeted Therapies. Berlin, Germany. March 2015.

6. Kokonou M, Issa K , Siaugue JM, Strongilos A, Agianian B, Stylianopoulos T, Odysseos A. «Resistance to Tyrosine Kinase Inhibitors in solid tumors is managed with nanofiber-based systems for in situ drug delivery». Industrial Technologies 2014. Athens, Greece. April 2014.

7. Issa K , Kettany N, Perrin J, Montemont C, Levy B. «Effects of Activated protein C and Dexamethasone in intestinal Ischemia/Reperfusion». 41th Congress of Reanimation Society of French Languiges SRLF. Paris, France. January 2013.

9. Kimmoun A, Issa K , Ducrocq N, Sennoun N, Montemont C, Gibot S, Levy B. «Bicarbonate with PaCO2 and calcemia normalization does restore cardiovascular performance in severe lactic acidotic rats». 38th Congress of Reanimation Society of French Languiges SRLF. Paris, France. January 2010.

10. Issa K , Collin S, Montemont C, Gibot S, Levy B. « Effects of Hydrogen Sulfide in a rat model of Ischemia Reperfusion ». 38th Congress of Reanimation Society of French Languiges SRLF. Paris, France. January 2010.

11. Issa K ,Collin S, Montemont C, Gibot S, Levy B. « Effects of Hydrogen Sulfide in a rat model of Ischemia Reperfusion ». 27th congress of biology and pathology of heart and vessels (GRRC) . Nante, France. May 2010.


Podium Presentation:

1. Stylianou P, Issa K , Iliopoulou S, Davila- Ibanez AB, Siaugue JM, Stylianopoulos T, Pitris C, Odysseos A «Silica-Coated Core-Shell Nanoparticles define a Novel Theranostic System for Targeted Drug Delivery to Nuclear-Translocated phospho-EGFR» ICoN, Limassol, Cyprus. October 2015

2. Issa K , Dessalles N, Kimmoun A, Strub C, Levy B. « Effets de la modulation β-1 adrénergique sur la cardiopathie septique» 41th Congress of Reanimation Society of French Languiges SRLF. Paris, France. January 2013.

3. Issa K , Collin S, Gibot S, Levy B. « Effects of Hydrogen Sulfide in a rat model of Ischemia/Reperfusion » 38th Congress of Reanimation Society of French Languiges SRLF. Paris, France. January 2010.

§ Issa K ,Collin S, Gibot S, Levy B. « Study of a new gasotransmitter, hydrogen sulfide in a model of hemorrhagic shock» One day of research Claude Huriet. Nancy, France. December 2009.

Software

Image analysis and processing software

Statistical software (SAS, JMP, GraphPad Prism, and SPSS)

PCR primer design software (Sequencher, Vector NTI, and Oligo 7)

Data Acquisition system: IOX (EMKA), Chart (Power lab), Acqknowledge (Biopac), Cardiomax (Pymep)

Timeline

Research Scientist - Proteomics, Inflammatory Response Mass Spectrometry (PRISM) Laboratory, Inserm U1192
10.2021 - 05.2023
Head of Molecular Diagnostics Department - Doctors' Center Laboratory
07.2019 - 09.2021
Research Project Manager - American University of Beirut Medical Center (AUBMC)
03.2016 - 03.2021
Postdoctoral Research Fellow - Marie Skłodowska-Curie fellowship « Nanoresistance »
09.2013 - 08.2015
Doctoral Researcher - Laboratoire de Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), INSERM (UMR_1116)
09.2009 - 06.2013
Faculty of Medicine, Lorraine University - Ph.D., Life Sciences And Health (Molecular Biology & Pharmacology)
09.2009 - 06.2013
Internship Trainer - Laboratoire de Défaillance Cardiovasculaire Aiguë et Chronique (DCAC), INSERM (UMR_1116)
01.2009 - 07.2009
Faculty of Pharmacy, Henri Poincare University - Master of Science, Bioengineering And Pharmacology
09.2008 - 07.2009
Faculty of Sciences, Henri Poincare University - Master of Science, Molecular Biology And Biochemistry
09.2007 - 07.2008
Faculty of Sciences, Lebanese University - Bachelor of Science, Biochemistry
10.2002 - 06.2006

Certified [Clinical Research Coordinator (CRC) Advanced], [CITI]

Certified [Biomedical Responsible Conduct of Research], [CITI]

Certified [Biomedical Research - Basic/Refresher], [CITI]

Licensed [Animal Experimentation (Level 1) and small surgery]

Khodr ISSAResearch And Development Scientist